ECSP045322A - Formulaciones de un anhidrato en suspensión con hfa - Google Patents

Formulaciones de un anhidrato en suspensión con hfa

Info

Publication number
ECSP045322A
ECSP045322A EC2004005322A ECSP045322A ECSP045322A EC SP045322 A ECSP045322 A EC SP045322A EC 2004005322 A EC2004005322 A EC 2004005322A EC SP045322 A ECSP045322 A EC SP045322A EC SP045322 A ECSP045322 A EC SP045322A
Authority
EC
Ecuador
Prior art keywords
hfa
hid
formulations
suspension
hydroxidi
Prior art date
Application number
EC2004005322A
Other languages
English (en)
Spanish (es)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of ECSP045322A publication Critical patent/ECSP045322A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
EC2004005322A 2002-03-28 2004-09-28 Formulaciones de un anhidrato en suspensión con hfa ECSP045322A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10214264A DE10214264A1 (de) 2002-03-28 2002-03-28 HFA-Suspensionsformulierungen eines Anhydrats

Publications (1)

Publication Number Publication Date
ECSP045322A true ECSP045322A (es) 2005-01-28

Family

ID=28050990

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2004005322A ECSP045322A (es) 2002-03-28 2004-09-28 Formulaciones de un anhidrato en suspensión con hfa

Country Status (21)

Country Link
EP (1) EP1492498A2 (ja)
JP (1) JP5147158B2 (ja)
KR (1) KR101005717B1 (ja)
CN (1) CN1642525A (ja)
AU (1) AU2003221509B2 (ja)
BR (1) BR0308709A (ja)
CA (1) CA2479638C (ja)
DE (1) DE10214264A1 (ja)
EA (1) EA008610B1 (ja)
EC (1) ECSP045322A (ja)
HR (1) HRP20040890A2 (ja)
IL (1) IL163696A0 (ja)
ME (1) ME00246B (ja)
MX (1) MXPA04009338A (ja)
NO (1) NO20044004L (ja)
NZ (1) NZ536030A (ja)
PL (1) PL371295A1 (ja)
RS (1) RS52481B (ja)
UA (1) UA79776C2 (ja)
WO (1) WO2003082244A2 (ja)
ZA (1) ZA200405637B (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2007144531A (ru) * 2005-05-02 2009-06-10 БЕРИНГЕР ИНГЕЛЬХАЙМ ИНТЕРНАЦИОНАЛЬ ГмбХ (DE) Новые кристаллические формы тиотропийбромида
AU2006243238B2 (en) * 2005-05-02 2012-05-24 Boehringer Ingelheim International Gmbh Novel crystalline forms of tiotropium bromide
AU2015201037C1 (en) * 2009-05-29 2017-07-27 Pearl Therapeutics, Inc. Respiratory delivery of active agents
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
PL3111926T3 (pl) * 2009-05-29 2020-06-29 Pearl Therapeutics, Inc. Kompozycje, sposoby i układy do dostarczania dwóch lub większej liczby środków czynnych do układu oddechowego
US20140275517A1 (en) 2013-03-15 2014-09-18 Pearl Therapeutics, Inc. Methods and systems for conditioning of particulate crystalline materials
JP6781831B2 (ja) * 2016-09-19 2020-11-04 メキシケム フロー エセ・ア・デ・セ・ヴェ 医薬組成物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3931041C2 (de) * 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
EP1102579B1 (de) * 1998-08-04 2003-03-19 Jago Research Ag Medizinische aerosolformulierungen
GB0009605D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Medicaments
GB0009583D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Respiratory formulations
GB0009606D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Therapeutic combinations
GB0009592D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Respiratory combinations
DE10113366A1 (de) * 2001-03-20 2002-09-26 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Endothelinantagonisten
DE50115277D1 (de) * 2000-10-31 2010-02-04 Boehringer Ingelheim Pharma Arzneimittelkompositionen aus tiotropiumsalzen und
DE10111058A1 (de) * 2001-03-08 2002-09-12 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und NK¶1¶-Rezeptor-Antagonisten

Also Published As

Publication number Publication date
BR0308709A (pt) 2005-01-04
JP2005527550A (ja) 2005-09-15
UA79776C2 (en) 2007-07-25
JP5147158B2 (ja) 2013-02-20
HRP20040890A2 (en) 2005-06-30
RS52481B (en) 2013-02-28
MXPA04009338A (es) 2005-01-25
NZ536030A (en) 2006-07-28
AU2003221509A1 (en) 2003-10-13
EP1492498A2 (de) 2005-01-05
DE10214264A1 (de) 2003-10-16
CN1642525A (zh) 2005-07-20
AU2003221509B2 (en) 2008-01-24
ZA200405637B (en) 2005-07-27
KR101005717B1 (ko) 2011-01-05
WO2003082244A2 (de) 2003-10-09
IL163696A0 (en) 2005-12-18
CA2479638C (en) 2011-01-04
PL371295A1 (en) 2005-06-13
MEP47308A (en) 2011-02-10
EA200401159A1 (ru) 2005-04-28
ME00246B (me) 2011-05-10
EA008610B1 (ru) 2007-06-29
CA2479638A1 (en) 2003-10-09
WO2003082244A3 (de) 2004-02-05
KR20040098022A (ko) 2004-11-18
YU86004A (sh) 2006-08-17
NO20044004L (no) 2004-10-05

Similar Documents

Publication Publication Date Title
BR0116444A (pt) Processo para a preparação de brometo de tiotrópio anticolinérgico
MXPA03011197A (es) Benzoilsufonamidas y sulfonilbenzamidinas que se usan como agentes antitumorales.
YU82303A (sh) Analozi nociceptina
JO2654B1 (en) Multiple aryl caroxa amides are useful as lipid - lowering agents
CO5590894A2 (es) Derivados de a-(n-sulfonamido)acetamida como inhibidores del peptido b-amiloideo
TW200738672A (en) Intermediated for the preparation of 4,5-dihydro-pyrazolo [3,4-c] pyrid-2-ones
IL158485A0 (en) Spiropyrazole compounds
CY1106247T1 (el) Θειοφαινο- και θειαζολοσουλφοναμιδες ως αντινεοπλαστικοι παραγοντες
GB0127903D0 (en) Improvements relating to organic compounds
MXPA03009602A (es) Analogos de nociceptina.
ECSP045322A (es) Formulaciones de un anhidrato en suspensión con hfa
RS50229B (sr) Analozi vitamina d3
ECSP045321A (es) Formulaciones en suspensión con hfa que contienen un anticolinérgico
SG136958A1 (en) Antagonistic analogs of gh-rh (2003)
MXPA04003755A (es) Endoprotesis vasculares.
BR0115139A (pt) Compostos bis-heterocìclicos com atividade antitumor e quimiossensibilizante
PL348509A1 (en) Production of ascorbic acid using yeast
PL363355A1 (en) Cyclization process step in the making of quinolones and naphthyridines
PL355442A1 (en) Substituted homopiperidinyl benzimidazole analogues as fundic relaxants
ATE243362T1 (de) Phosphor-überzug für gasentladungslampen
MXPA04004090A (es) Compuestos substituidos de 1h-quinolin-2-ona.
AU2002339174A1 (en) Light emitting device and compounds for use therein
NO20011578D0 (no) Anvendelse av acylkarnitiner som antitumormidler
BR9907541A (pt) Aparelho reator de gases a ar comprimido e sistema descendente
ECSP992912A (es) Ligandos azabiciclicos de receptores 5ht1